Bloating in Gastroparesis: Severity, Impact, and Associated Factors-Reference-Cited by-同舟云学术

Bloating in Gastroparesis: Severity, Impact, and Associated Factors

Published:2011-08 Issue:8 Volume:106 Page:1492-1502
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Hasler William L,Wilson Laura A,Parkman Henry P,Nguyen Linda,Abell Thomas L,Koch Kenneth L,Pasricha Pankaj J,Snape William J,Farrugia Gianrico,Lee Linda,Tonascia James,Unalp-Arida Aynur,Hamilton Frank

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg201181.pdf

Reference36 articles.

1. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.;Revicki;Aliment Pharmacol Ther,2003

2. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.;Arts;Aliment Pharmacol Ther,2006

3. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors.;Anaparthy;Dig Dis Sci,2009

4. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.;Ringel;Clin Gastroenterol Hepatol,2009

5. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.;Jiang;Gut,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroparesis: guidelines for effective management;Gastroenterology & Hepatology: Open access;2024-07-18

2. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review;Gastroenterology;2023-09

3. Buspirone for early satiety and symptoms of gastroparesis: A multi‐centre, randomised, placebo‐controlled, double‐masked trial (BESST);Alimentary Pharmacology & Therapeutics;2023-04-13

4. Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities;Expert Opinion on Investigational Drugs;2023-03-04

5. Understanding symptoms of gastric dysmotility: Nausea, vomiting, abdominal pain, postprandial fullness, and early satiety;Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions;2023